The global market for Biological Pentylenediamine for Medicine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Pentylenediamine, also known as 1,5-diaminopentane, is an important C5 platform compound. It is a colorless fuming liquid with an odor similar to ammonia gas and is easily soluble in water and ethanol. Kasai uses renewable plant resources as raw materials to produce high-purity biological pentylenediamine through specific biological transformation process.

Pentylenediamine can be used in polyamide, pentamethylene diisocyanate (PDI), epoxy resin curing agent, organic synthesis intermediates, etc., and can be further used in spinning, engineering materials, medicine, pesticides, organic synthesis and other fields.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biological Pentylenediamine for Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biological Pentylenediamine for Medicine.

The Biological Pentylenediamine for Medicine market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biological Pentylenediamine for Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biological Pentylenediamine for Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Biological Pentylenediamine for Medicine Market Report

Report Metric	Details
Report Name	Biological Pentylenediamine for Medicine Market
CAGR	5%
by Type	Purity＜99.5% Purity ＞ 99.5%
by Application	Pharmaceutical Industry Medical Research Others
Production by Region	North America Europe China Japan
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Cathay Biotech, Aphena Pharma Solutions, Bio-Tech Pharmacal, Goodwin Biotechnology, Xenon Pharmaceuticals, Nektar Therapeutics, Midas Pharmaceuticals, Kedrion Biopharma, Xcelthera, Anichem, ALC Bio Innovations, ACADIA Pharmaceuticals, AbbVie, Ology Bioservices, QMI - Quality Management, Biomiga, Molecular Targeting Technologies
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biological Pentylenediamine for Medicine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Biological Pentylenediamine for Medicine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Biological Pentylenediamine for Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Biological Pentylenediamine for Medicine Market report?

Ans: The main players in the Biological Pentylenediamine for Medicine Market are Cathay Biotech, Aphena Pharma Solutions, Bio-Tech Pharmacal, Goodwin Biotechnology, Xenon Pharmaceuticals, Nektar Therapeutics, Midas Pharmaceuticals, Kedrion Biopharma, Xcelthera, Anichem, ALC Bio Innovations, ACADIA Pharmaceuticals, AbbVie, Ology Bioservices, QMI - Quality Management, Biomiga, Molecular Targeting Technologies

What are the Application segmentation covered in the Biological Pentylenediamine for Medicine Market report?

Ans: The Applications covered in the Biological Pentylenediamine for Medicine Market report are Pharmaceutical Industry, Medical Research, Others

What are the Type segmentation covered in the Biological Pentylenediamine for Medicine Market report?

Ans: The Types covered in the Biological Pentylenediamine for Medicine Market report are Purity＜99.5%, Purity ＞ 99.5%

1 Biological Pentylenediamine for Medicine Market Overview

1.1 Product Definition

1.2 Biological Pentylenediamine for Medicine by Type

1.2.1 Global Biological Pentylenediamine for Medicine Market Value Growth Rate Analysis by Type: 2024 VS 2031

1.2.2 Purity＜99.5%

1.2.3 Purity ＞ 99.5%

1.3 Biological Pentylenediamine for Medicine by Application

1.3.1 Global Biological Pentylenediamine for Medicine Market Value Growth Rate Analysis by Application: 2024 VS 2031

1.3.2 Pharmaceutical Industry

1.3.3 Medical Research

1.3.4 Others

1.4 Global Market Growth Prospects

1.4.1 Global Biological Pentylenediamine for Medicine Production Value Estimates and Forecasts (2020-2031)

1.4.2 Global Biological Pentylenediamine for Medicine Production Capacity Estimates and Forecasts (2020-2031)

1.4.3 Global Biological Pentylenediamine for Medicine Production Estimates and Forecasts (2020-2031)

1.4.4 Global Biological Pentylenediamine for Medicine Market Average Price Estimates and Forecasts (2020-2031)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Biological Pentylenediamine for Medicine Production Market Share by Manufacturers (2020-2025)

2.2 Global Biological Pentylenediamine for Medicine Production Value Market Share by Manufacturers (2020-2025)

2.3 Global Key Players of Biological Pentylenediamine for Medicine, Industry Ranking, 2023 VS 2024

2.4 Global Biological Pentylenediamine for Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.5 Global Biological Pentylenediamine for Medicine Average Price by Manufacturers (2020-2025)

2.6 Global Key Manufacturers of Biological Pentylenediamine for Medicine, Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of Biological Pentylenediamine for Medicine, Product Offered and Application

2.8 Global Key Manufacturers of Biological Pentylenediamine for Medicine, Date of Enter into This Industry

2.9 Biological Pentylenediamine for Medicine Market Competitive Situation and Trends

2.9.1 Biological Pentylenediamine for Medicine Market Concentration Rate

2.9.2 Global 5 and 10 Largest Biological Pentylenediamine for Medicine Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3 Biological Pentylenediamine for Medicine Production by Region

3.1 Global Biological Pentylenediamine for Medicine Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.2 Global Biological Pentylenediamine for Medicine Production Value by Region (2020-2031)

3.2.1 Global Biological Pentylenediamine for Medicine Production Value by Region (2020-2025)

3.2.2 Global Forecasted Production Value of Biological Pentylenediamine for Medicine by Region (2026-2031)

3.3 Global Biological Pentylenediamine for Medicine Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.4 Global Biological Pentylenediamine for Medicine Production Volume by Region (2020-2031)

3.4.1 Global Biological Pentylenediamine for Medicine Production by Region (2020-2025)

3.4.2 Global Forecasted Production of Biological Pentylenediamine for Medicine by Region (2026-2031)

3.5 Global Biological Pentylenediamine for Medicine Market Price Analysis by Region (2020-2025)

3.6 Global Biological Pentylenediamine for Medicine Production and Value, Year-over-Year Growth

3.6.1 North America Biological Pentylenediamine for Medicine Production Value Estimates and Forecasts (2020-2031)

3.6.2 Europe Biological Pentylenediamine for Medicine Production Value Estimates and Forecasts (2020-2031)

3.6.3 China Biological Pentylenediamine for Medicine Production Value Estimates and Forecasts (2020-2031)

3.6.4 Japan Biological Pentylenediamine for Medicine Production Value Estimates and Forecasts (2020-2031)

4 Biological Pentylenediamine for Medicine Consumption by Region

4.1 Global Biological Pentylenediamine for Medicine Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

4.2 Global Biological Pentylenediamine for Medicine Consumption by Region (2020-2031)

4.2.1 Global Biological Pentylenediamine for Medicine Consumption by Region (2020-2025)

4.2.2 Global Biological Pentylenediamine for Medicine Forecasted Consumption by Region (2026-2031)

4.3 North America

4.3.1 North America Biological Pentylenediamine for Medicine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.3.2 North America Biological Pentylenediamine for Medicine Consumption by Country (2020-2031)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Biological Pentylenediamine for Medicine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.4.2 Europe Biological Pentylenediamine for Medicine Consumption by Country (2020-2031)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Biological Pentylenediamine for Medicine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031

4.5.2 Asia Pacific Biological Pentylenediamine for Medicine Consumption by Region (2020-2031)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Biological Pentylenediamine for Medicine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.6.2 Latin America, Middle East & Africa Biological Pentylenediamine for Medicine Consumption by Country (2020-2031)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Biological Pentylenediamine for Medicine Production by Type (2020-2031)

5.1.1 Global Biological Pentylenediamine for Medicine Production by Type (2020-2025)

5.1.2 Global Biological Pentylenediamine for Medicine Production by Type (2026-2031)

5.1.3 Global Biological Pentylenediamine for Medicine Production Market Share by Type (2020-2031)

5.2 Global Biological Pentylenediamine for Medicine Production Value by Type (2020-2031)

5.2.1 Global Biological Pentylenediamine for Medicine Production Value by Type (2020-2025)

5.2.2 Global Biological Pentylenediamine for Medicine Production Value by Type (2026-2031)

5.2.3 Global Biological Pentylenediamine for Medicine Production Value Market Share by Type (2020-2031)

5.3 Global Biological Pentylenediamine for Medicine Price by Type (2020-2031)

6 Segment by Application

6.1 Global Biological Pentylenediamine for Medicine Production by Application (2020-2031)

6.1.1 Global Biological Pentylenediamine for Medicine Production by Application (2020-2025)

6.1.2 Global Biological Pentylenediamine for Medicine Production by Application (2026-2031)

6.1.3 Global Biological Pentylenediamine for Medicine Production Market Share by Application (2020-2031)

6.2 Global Biological Pentylenediamine for Medicine Production Value by Application (2020-2031)

6.2.1 Global Biological Pentylenediamine for Medicine Production Value by Application (2020-2025)

6.2.2 Global Biological Pentylenediamine for Medicine Production Value by Application (2026-2031)

6.2.3 Global Biological Pentylenediamine for Medicine Production Value Market Share by Application (2020-2031)

6.3 Global Biological Pentylenediamine for Medicine Price by Application (2020-2031)

7 Key Companies Profiled

7.1 Cathay Biotech

7.1.1 Cathay Biotech Biological Pentylenediamine for Medicine Company Information

7.1.2 Cathay Biotech Biological Pentylenediamine for Medicine Product Portfolio

7.1.3 Cathay Biotech Biological Pentylenediamine for Medicine Production, Value, Price and Gross Margin (2020-2025)

7.1.4 Cathay Biotech Main Business and Markets Served

7.1.5 Cathay Biotech Recent Developments/Updates

7.2 Aphena Pharma Solutions

7.2.1 Aphena Pharma Solutions Biological Pentylenediamine for Medicine Company Information

7.2.2 Aphena Pharma Solutions Biological Pentylenediamine for Medicine Product Portfolio

7.2.3 Aphena Pharma Solutions Biological Pentylenediamine for Medicine Production, Value, Price and Gross Margin (2020-2025)

7.2.4 Aphena Pharma Solutions Main Business and Markets Served

7.2.5 Aphena Pharma Solutions Recent Developments/Updates

7.3 Bio-Tech Pharmacal

7.3.1 Bio-Tech Pharmacal Biological Pentylenediamine for Medicine Company Information

7.3.2 Bio-Tech Pharmacal Biological Pentylenediamine for Medicine Product Portfolio

7.3.3 Bio-Tech Pharmacal Biological Pentylenediamine for Medicine Production, Value, Price and Gross Margin (2020-2025)

7.3.4 Bio-Tech Pharmacal Main Business and Markets Served

7.3.5 Bio-Tech Pharmacal Recent Developments/Updates

7.4 Goodwin Biotechnology

7.4.1 Goodwin Biotechnology Biological Pentylenediamine for Medicine Company Information

7.4.2 Goodwin Biotechnology Biological Pentylenediamine for Medicine Product Portfolio

7.4.3 Goodwin Biotechnology Biological Pentylenediamine for Medicine Production, Value, Price and Gross Margin (2020-2025)

7.4.4 Goodwin Biotechnology Main Business and Markets Served

7.4.5 Goodwin Biotechnology Recent Developments/Updates

7.5 Xenon Pharmaceuticals

7.5.1 Xenon Pharmaceuticals Biological Pentylenediamine for Medicine Company Information

7.5.2 Xenon Pharmaceuticals Biological Pentylenediamine for Medicine Product Portfolio

7.5.3 Xenon Pharmaceuticals Biological Pentylenediamine for Medicine Production, Value, Price and Gross Margin (2020-2025)

7.5.4 Xenon Pharmaceuticals Main Business and Markets Served

7.5.5 Xenon Pharmaceuticals Recent Developments/Updates

7.6 Nektar Therapeutics

7.6.1 Nektar Therapeutics Biological Pentylenediamine for Medicine Company Information

7.6.2 Nektar Therapeutics Biological Pentylenediamine for Medicine Product Portfolio

7.6.3 Nektar Therapeutics Biological Pentylenediamine for Medicine Production, Value, Price and Gross Margin (2020-2025)

7.6.4 Nektar Therapeutics Main Business and Markets Served

7.6.5 Nektar Therapeutics Recent Developments/Updates

7.7 Midas Pharmaceuticals

7.7.1 Midas Pharmaceuticals Biological Pentylenediamine for Medicine Company Information

7.7.2 Midas Pharmaceuticals Biological Pentylenediamine for Medicine Product Portfolio

7.7.3 Midas Pharmaceuticals Biological Pentylenediamine for Medicine Production, Value, Price and Gross Margin (2020-2025)

7.7.4 Midas Pharmaceuticals Main Business and Markets Served

7.7.5 Midas Pharmaceuticals Recent Developments/Updates

7.8 Kedrion Biopharma

7.8.1 Kedrion Biopharma Biological Pentylenediamine for Medicine Company Information

7.8.2 Kedrion Biopharma Biological Pentylenediamine for Medicine Product Portfolio

7.8.3 Kedrion Biopharma Biological Pentylenediamine for Medicine Production, Value, Price and Gross Margin (2020-2025)

7.8.4 Kedrion Biopharma Main Business and Markets Served

7.8.5 Kedrion Biopharma Recent Developments/Updates

7.9 Xcelthera

7.9.1 Xcelthera Biological Pentylenediamine for Medicine Company Information

7.9.2 Xcelthera Biological Pentylenediamine for Medicine Product Portfolio

7.9.3 Xcelthera Biological Pentylenediamine for Medicine Production, Value, Price and Gross Margin (2020-2025)

7.9.4 Xcelthera Main Business and Markets Served

7.9.5 Xcelthera Recent Developments/Updates

7.10 Anichem

7.10.1 Anichem Biological Pentylenediamine for Medicine Company Information

7.10.2 Anichem Biological Pentylenediamine for Medicine Product Portfolio

7.10.3 Anichem Biological Pentylenediamine for Medicine Production, Value, Price and Gross Margin (2020-2025)

7.10.4 Anichem Main Business and Markets Served

7.10.5 Anichem Recent Developments/Updates

7.11 ALC Bio Innovations

7.11.1 ALC Bio Innovations Biological Pentylenediamine for Medicine Company Information

7.11.2 ALC Bio Innovations Biological Pentylenediamine for Medicine Product Portfolio

7.11.3 ALC Bio Innovations Biological Pentylenediamine for Medicine Production, Value, Price and Gross Margin (2020-2025)

7.11.4 ALC Bio Innovations Main Business and Markets Served

7.11.5 ALC Bio Innovations Recent Developments/Updates

7.12 ACADIA Pharmaceuticals

7.12.1 ACADIA Pharmaceuticals Biological Pentylenediamine for Medicine Company Information

7.12.2 ACADIA Pharmaceuticals Biological Pentylenediamine for Medicine Product Portfolio

7.12.3 ACADIA Pharmaceuticals Biological Pentylenediamine for Medicine Production, Value, Price and Gross Margin (2020-2025)

7.12.4 ACADIA Pharmaceuticals Main Business and Markets Served

7.12.5 ACADIA Pharmaceuticals Recent Developments/Updates

7.13 AbbVie

7.13.1 AbbVie Biological Pentylenediamine for Medicine Company Information

7.13.2 AbbVie Biological Pentylenediamine for Medicine Product Portfolio

7.13.3 AbbVie Biological Pentylenediamine for Medicine Production, Value, Price and Gross Margin (2020-2025)

7.13.4 AbbVie Main Business and Markets Served

7.13.5 AbbVie Recent Developments/Updates

7.14 Ology Bioservices

7.14.1 Ology Bioservices Biological Pentylenediamine for Medicine Company Information

7.14.2 Ology Bioservices Biological Pentylenediamine for Medicine Product Portfolio

7.14.3 Ology Bioservices Biological Pentylenediamine for Medicine Production, Value, Price and Gross Margin (2020-2025)

7.14.4 Ology Bioservices Main Business and Markets Served

7.14.5 Ology Bioservices Recent Developments/Updates

7.15 QMI - Quality Management

7.15.1 QMI - Quality Management Biological Pentylenediamine for Medicine Company Information

7.15.2 QMI - Quality Management Biological Pentylenediamine for Medicine Product Portfolio

7.15.3 QMI - Quality Management Biological Pentylenediamine for Medicine Production, Value, Price and Gross Margin (2020-2025)

7.15.4 QMI - Quality Management Main Business and Markets Served

7.15.5 QMI - Quality Management Recent Developments/Updates

7.16 Biomiga

7.16.1 Biomiga Biological Pentylenediamine for Medicine Company Information

7.16.2 Biomiga Biological Pentylenediamine for Medicine Product Portfolio

7.16.3 Biomiga Biological Pentylenediamine for Medicine Production, Value, Price and Gross Margin (2020-2025)

7.16.4 Biomiga Main Business and Markets Served

7.16.5 Biomiga Recent Developments/Updates

7.17 Molecular Targeting Technologies

7.17.1 Molecular Targeting Technologies Biological Pentylenediamine for Medicine Company Information

7.17.2 Molecular Targeting Technologies Biological Pentylenediamine for Medicine Product Portfolio

7.17.3 Molecular Targeting Technologies Biological Pentylenediamine for Medicine Production, Value, Price and Gross Margin (2020-2025)

7.17.4 Molecular Targeting Technologies Main Business and Markets Served

7.17.5 Molecular Targeting Technologies Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Biological Pentylenediamine for Medicine Industry Chain Analysis

8.2 Biological Pentylenediamine for Medicine Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Biological Pentylenediamine for Medicine Production Mode & Process Analysis

8.4 Biological Pentylenediamine for Medicine Sales and Marketing

8.4.1 Biological Pentylenediamine for Medicine Sales Channels

8.4.2 Biological Pentylenediamine for Medicine Distributors

8.5 Biological Pentylenediamine for Medicine Customer Analysis

9 Biological Pentylenediamine for Medicine Market Dynamics

9.1 Biological Pentylenediamine for Medicine Industry Trends

9.2 Biological Pentylenediamine for Medicine Market Drivers

9.3 Biological Pentylenediamine for Medicine Market Challenges

9.4 Biological Pentylenediamine for Medicine Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

FEATURED COMPANIES

Aphena Pharma Solutions

Bio-Tech Pharmacal

Goodwin Biotechnology

Xenon Pharmaceuticals

Nektar Therapeutics

Midas Pharmaceuticals

ACADIA Pharmaceuticals

AbbVie

Ology Bioservices

QMI - Quality Management

Biomiga

Molecular Targeting Technologies

Cathay Biotech

List of Tables

Table 1. Global Biological Pentylenediamine for Medicine Market Value by Type, (US$ Million) & (2024 VS 2031)

Table 2. Global Biological Pentylenediamine for Medicine Market Value by Application, (US$ Million) & (2024 VS 2031)

Table 3. Global Biological Pentylenediamine for Medicine Production Capacity (Tons) by Manufacturers in 2024

Table 4. Global Biological Pentylenediamine for Medicine Production by Manufacturers (2020-2025) & (Tons)

Table 5. Global Biological Pentylenediamine for Medicine Production Market Share by Manufacturers (2020-2025)

Table 6. Global Biological Pentylenediamine for Medicine Production Value by Manufacturers (2020-2025) & (US$ Million)

Table 7. Global Biological Pentylenediamine for Medicine Production Value Share by Manufacturers (2020-2025)

Table 8. Global Key Players of Biological Pentylenediamine for Medicine, Industry Ranking, 2023 VS 2024

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Biological Pentylenediamine for Medicine as of 2024)

Table 10. Global Market Biological Pentylenediamine for Medicine Average Price by Manufacturers (US$/Ton) & (2020-2025)

Table 11. Global Key Manufacturers of Biological Pentylenediamine for Medicine, Manufacturing Base Distribution and Headquarters

Table 12. Global Key Manufacturers of Biological Pentylenediamine for Medicine, Product Offered and Application

Table 13. Global Key Manufacturers of Biological Pentylenediamine for Medicine, Date of Enter into This Industry

Table 14. Global Biological Pentylenediamine for Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Biological Pentylenediamine for Medicine Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Biological Pentylenediamine for Medicine Production Value (US$ Million) by Region (2020-2025)

Table 18. Global Biological Pentylenediamine for Medicine Production Value Market Share by Region (2020-2025)

Table 19. Global Biological Pentylenediamine for Medicine Production Value (US$ Million) Forecast by Region (2026-2031)

Table 20. Global Biological Pentylenediamine for Medicine Production Value Market Share Forecast by Region (2026-2031)

Table 21. Global Biological Pentylenediamine for Medicine Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)

Table 22. Global Biological Pentylenediamine for Medicine Production (Tons) by Region (2020-2025)

Table 23. Global Biological Pentylenediamine for Medicine Production Market Share by Region (2020-2025)

Table 24. Global Biological Pentylenediamine for Medicine Production (Tons) Forecast by Region (2026-2031)

Table 25. Global Biological Pentylenediamine for Medicine Production Market Share Forecast by Region (2026-2031)

Table 26. Global Biological Pentylenediamine for Medicine Market Average Price (US$/Ton) by Region (2020-2025)

Table 27. Global Biological Pentylenediamine for Medicine Market Average Price (US$/Ton) by Region (2026-2031)

Table 28. Global Biological Pentylenediamine for Medicine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)

Table 29. Global Biological Pentylenediamine for Medicine Consumption by Region (2020-2025) & (Tons)

Table 30. Global Biological Pentylenediamine for Medicine Consumption Market Share by Region (2020-2025)

Table 31. Global Biological Pentylenediamine for Medicine Forecasted Consumption by Region (2026-2031) & (Tons)

Table 32. Global Biological Pentylenediamine for Medicine Forecasted Consumption Market Share by Region (2026-2031)

Table 33. North America Biological Pentylenediamine for Medicine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)

Table 34. North America Biological Pentylenediamine for Medicine Consumption by Country (2020-2025) & (Tons)

Table 35. North America Biological Pentylenediamine for Medicine Consumption by Country (2026-2031) & (Tons)

Table 36. Europe Biological Pentylenediamine for Medicine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)

Table 37. Europe Biological Pentylenediamine for Medicine Consumption by Country (2020-2025) & (Tons)

Table 38. Europe Biological Pentylenediamine for Medicine Consumption by Country (2026-2031) & (Tons)

Table 39. Asia Pacific Biological Pentylenediamine for Medicine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)

Table 40. Asia Pacific Biological Pentylenediamine for Medicine Consumption by Region (2020-2025) & (Tons)

Table 41. Asia Pacific Biological Pentylenediamine for Medicine Consumption by Region (2026-2031) & (Tons)

Table 42. Latin America, Middle East & Africa Biological Pentylenediamine for Medicine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)

Table 43. Latin America, Middle East & Africa Biological Pentylenediamine for Medicine Consumption by Country (2020-2025) & (Tons)

Table 44. Latin America, Middle East & Africa Biological Pentylenediamine for Medicine Consumption by Country (2026-2031) & (Tons)

Table 45. Global Biological Pentylenediamine for Medicine Production (Tons) by Type (2020-2025)

Table 46. Global Biological Pentylenediamine for Medicine Production (Tons) by Type (2026-2031)

Table 47. Global Biological Pentylenediamine for Medicine Production Market Share by Type (2020-2025)

Table 48. Global Biological Pentylenediamine for Medicine Production Market Share by Type (2026-2031)

Table 49. Global Biological Pentylenediamine for Medicine Production Value (US$ Million) by Type (2020-2025)

Table 50. Global Biological Pentylenediamine for Medicine Production Value (US$ Million) by Type (2026-2031)

Table 51. Global Biological Pentylenediamine for Medicine Production Value Market Share by Type (2020-2025)

Table 52. Global Biological Pentylenediamine for Medicine Production Value Market Share by Type (2026-2031)

Table 53. Global Biological Pentylenediamine for Medicine Price (US$/Ton) by Type (2020-2025)

Table 54. Global Biological Pentylenediamine for Medicine Price (US$/Ton) by Type (2026-2031)

Table 55. Global Biological Pentylenediamine for Medicine Production (Tons) by Application (2020-2025)

Table 56. Global Biological Pentylenediamine for Medicine Production (Tons) by Application (2026-2031)

Table 57. Global Biological Pentylenediamine for Medicine Production Market Share by Application (2020-2025)

Table 58. Global Biological Pentylenediamine for Medicine Production Market Share by Application (2026-2031)

Table 59. Global Biological Pentylenediamine for Medicine Production Value (US$ Million) by Application (2020-2025)

Table 60. Global Biological Pentylenediamine for Medicine Production Value (US$ Million) by Application (2026-2031)

Table 61. Global Biological Pentylenediamine for Medicine Production Value Market Share by Application (2020-2025)

Table 62. Global Biological Pentylenediamine for Medicine Production Value Market Share by Application (2026-2031)

Table 63. Global Biological Pentylenediamine for Medicine Price (US$/Ton) by Application (2020-2025)

Table 64. Global Biological Pentylenediamine for Medicine Price (US$/Ton) by Application (2026-2031)

Table 65. Cathay Biotech Biological Pentylenediamine for Medicine Company Information

Table 66. Cathay Biotech Biological Pentylenediamine for Medicine Specification and Application

Table 67. Cathay Biotech Biological Pentylenediamine for Medicine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 68. Cathay Biotech Main Business and Markets Served

Table 69. Cathay Biotech Recent Developments/Updates

Table 70. Aphena Pharma Solutions Biological Pentylenediamine for Medicine Company Information

Table 71. Aphena Pharma Solutions Biological Pentylenediamine for Medicine Specification and Application

Table 72. Aphena Pharma Solutions Biological Pentylenediamine for Medicine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 73. Aphena Pharma Solutions Main Business and Markets Served

Table 74. Aphena Pharma Solutions Recent Developments/Updates

Table 75. Bio-Tech Pharmacal Biological Pentylenediamine for Medicine Company Information

Table 76. Bio-Tech Pharmacal Biological Pentylenediamine for Medicine Specification and Application

Table 77. Bio-Tech Pharmacal Biological Pentylenediamine for Medicine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 78. Bio-Tech Pharmacal Main Business and Markets Served

Table 79. Bio-Tech Pharmacal Recent Developments/Updates

Table 80. Goodwin Biotechnology Biological Pentylenediamine for Medicine Company Information

Table 81. Goodwin Biotechnology Biological Pentylenediamine for Medicine Specification and Application

Table 82. Goodwin Biotechnology Biological Pentylenediamine for Medicine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 83. Goodwin Biotechnology Main Business and Markets Served

Table 84. Goodwin Biotechnology Recent Developments/Updates

Table 85. Xenon Pharmaceuticals Biological Pentylenediamine for Medicine Company Information

Table 86. Xenon Pharmaceuticals Biological Pentylenediamine for Medicine Specification and Application

Table 87. Xenon Pharmaceuticals Biological Pentylenediamine for Medicine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 88. Xenon Pharmaceuticals Main Business and Markets Served

Table 89. Xenon Pharmaceuticals Recent Developments/Updates

Table 90. Nektar Therapeutics Biological Pentylenediamine for Medicine Company Information

Table 91. Nektar Therapeutics Biological Pentylenediamine for Medicine Specification and Application

Table 92. Nektar Therapeutics Biological Pentylenediamine for Medicine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 93. Nektar Therapeutics Main Business and Markets Served

Table 94. Nektar Therapeutics Recent Developments/Updates

Table 95. Midas Pharmaceuticals Biological Pentylenediamine for Medicine Company Information

Table 96. Midas Pharmaceuticals Biological Pentylenediamine for Medicine Specification and Application

Table 97. Midas Pharmaceuticals Biological Pentylenediamine for Medicine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 98. Midas Pharmaceuticals Main Business and Markets Served

Table 99. Midas Pharmaceuticals Recent Developments/Updates

Table 100. Kedrion Biopharma Biological Pentylenediamine for Medicine Company Information

Table 101. Kedrion Biopharma Biological Pentylenediamine for Medicine Specification and Application

Table 102. Kedrion Biopharma Biological Pentylenediamine for Medicine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 103. Kedrion Biopharma Main Business and Markets Served

Table 104. Kedrion Biopharma Recent Developments/Updates

Table 105. Xcelthera Biological Pentylenediamine for Medicine Company Information

Table 106. Xcelthera Biological Pentylenediamine for Medicine Specification and Application

Table 107. Xcelthera Biological Pentylenediamine for Medicine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 108. Xcelthera Main Business and Markets Served

Table 109. Xcelthera Recent Developments/Updates

Table 110. Anichem Biological Pentylenediamine for Medicine Company Information

Table 111. Anichem Biological Pentylenediamine for Medicine Specification and Application

Table 112. Anichem Biological Pentylenediamine for Medicine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 113. Anichem Main Business and Markets Served

Table 114. Anichem Recent Developments/Updates

Table 115. ALC Bio Innovations Biological Pentylenediamine for Medicine Company Information

Table 116. ALC Bio Innovations Biological Pentylenediamine for Medicine Specification and Application

Table 117. ALC Bio Innovations Biological Pentylenediamine for Medicine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 118. ALC Bio Innovations Main Business and Markets Served

Table 119. ALC Bio Innovations Recent Developments/Updates

Table 120. ACADIA Pharmaceuticals Biological Pentylenediamine for Medicine Company Information

Table 121. ACADIA Pharmaceuticals Biological Pentylenediamine for Medicine Specification and Application

Table 122. ACADIA Pharmaceuticals Biological Pentylenediamine for Medicine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 123. ACADIA Pharmaceuticals Main Business and Markets Served

Table 124. ACADIA Pharmaceuticals Recent Developments/Updates

Table 125. AbbVie Biological Pentylenediamine for Medicine Company Information

Table 126. AbbVie Biological Pentylenediamine for Medicine Specification and Application

Table 127. AbbVie Biological Pentylenediamine for Medicine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 128. AbbVie Main Business and Markets Served

Table 129. AbbVie Recent Developments/Updates

Table 130. Ology Bioservices Biological Pentylenediamine for Medicine Company Information

Table 131. Ology Bioservices Biological Pentylenediamine for Medicine Specification and Application

Table 132. Ology Bioservices Biological Pentylenediamine for Medicine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 133. Ology Bioservices Main Business and Markets Served

Table 134. Ology Bioservices Recent Developments/Updates

Table 135. QMI - Quality Management Biological Pentylenediamine for Medicine Company Information

Table 136. QMI - Quality Management Biological Pentylenediamine for Medicine Specification and Application

Table 137. QMI - Quality Management Biological Pentylenediamine for Medicine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 138. QMI - Quality Management Main Business and Markets Served

Table 139. QMI - Quality Management Recent Developments/Updates

Table 140. Biomiga Biological Pentylenediamine for Medicine Company Information

Table 141. Biomiga Biological Pentylenediamine for Medicine Specification and Application

Table 142. Biomiga Biological Pentylenediamine for Medicine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 143. Biomiga Main Business and Markets Served

Table 144. Biomiga Recent Developments/Updates

Table 145. Molecular Targeting Technologies Biological Pentylenediamine for Medicine Company Information

Table 146. Molecular Targeting Technologies Biological Pentylenediamine for Medicine Specification and Application

Table 147. Molecular Targeting Technologies Biological Pentylenediamine for Medicine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 148. Molecular Targeting Technologies Main Business and Markets Served

Table 149. Molecular Targeting Technologies Recent Developments/Updates

Table 150. Key Raw Materials Lists

Table 151. Raw Materials Key Suppliers Lists

Table 152. Biological Pentylenediamine for Medicine Distributors List

Table 153. Biological Pentylenediamine for Medicine Customers List

Table 154. Biological Pentylenediamine for Medicine Market Trends

Table 155. Biological Pentylenediamine for Medicine Market Drivers

Table 156. Biological Pentylenediamine for Medicine Market Challenges

Table 157. Biological Pentylenediamine for Medicine Market Restraints

Table 158. Research Programs/Design for This Report

Table 159. Key Data Information from Secondary Sources

Table 160. Key Data Information from Primary Sources

Table 161. Authors List of This Report

List of Figures

Figure 1. Product Picture of Biological Pentylenediamine for Medicine

Figure 2. Global Biological Pentylenediamine for Medicine Market Value by Type, (US$ Million) & (2020-2031)

Figure 3. Global Biological Pentylenediamine for Medicine Market Share by Type: 2024 VS 2031

Figure 4. Purity＜99.5% Product Picture

Figure 5. Purity ＞ 99.5% Product Picture

Figure 6. Global Biological Pentylenediamine for Medicine Market Value by Application, (US$ Million) & (2020-2031)

Figure 7. Global Biological Pentylenediamine for Medicine Market Share by Application: 2024 VS 2031

Figure 8. Pharmaceutical Industry

Figure 9. Medical Research

Figure 10. Others

Figure 11. Global Biological Pentylenediamine for Medicine Production Value (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Biological Pentylenediamine for Medicine Production Value (US$ Million) & (2020-2031)

Figure 13. Global Biological Pentylenediamine for Medicine Production Capacity (Tons) & (2020-2031)

Figure 14. Global Biological Pentylenediamine for Medicine Production (Tons) & (2020-2031)

Figure 15. Global Biological Pentylenediamine for Medicine Average Price (US$/Ton) & (2020-2031)

Figure 16. Biological Pentylenediamine for Medicine Report Years Considered

Figure 17. Biological Pentylenediamine for Medicine Production Share by Manufacturers in 2024

Figure 18. Global Biological Pentylenediamine for Medicine Production Value Share by Manufacturers (2024)

Figure 19. Biological Pentylenediamine for Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. The Global 5 and 10 Largest Players: Market Share by Biological Pentylenediamine for Medicine Revenue in 2024

Figure 21. Global Biological Pentylenediamine for Medicine Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 22. Global Biological Pentylenediamine for Medicine Production Value Market Share by Region: 2020 VS 2024 VS 2031

Figure 23. Global Biological Pentylenediamine for Medicine Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)

Figure 24. Global Biological Pentylenediamine for Medicine Production Market Share by Region: 2020 VS 2024 VS 2031

Figure 25. North America Biological Pentylenediamine for Medicine Production Value (US$ Million) Growth Rate (2020-2031)

Figure 26. Europe Biological Pentylenediamine for Medicine Production Value (US$ Million) Growth Rate (2020-2031)

Figure 27. China Biological Pentylenediamine for Medicine Production Value (US$ Million) Growth Rate (2020-2031)

Figure 28. Japan Biological Pentylenediamine for Medicine Production Value (US$ Million) Growth Rate (2020-2031)

Figure 29. Global Biological Pentylenediamine for Medicine Consumption by Region: 2020 VS 2024 VS 2031 (Tons)

Figure 30. Global Biological Pentylenediamine for Medicine Consumption Market Share by Region: 2020 VS 2024 VS 2031

Figure 31. North America Biological Pentylenediamine for Medicine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 32. North America Biological Pentylenediamine for Medicine Consumption Market Share by Country (2020-2031)

Figure 33. U.S. Biological Pentylenediamine for Medicine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 34. Canada Biological Pentylenediamine for Medicine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 35. Europe Biological Pentylenediamine for Medicine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 36. Europe Biological Pentylenediamine for Medicine Consumption Market Share by Country (2020-2031)

Figure 37. Germany Biological Pentylenediamine for Medicine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 38. France Biological Pentylenediamine for Medicine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 39. U.K. Biological Pentylenediamine for Medicine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 40. Italy Biological Pentylenediamine for Medicine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 41. Russia Biological Pentylenediamine for Medicine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 42. Asia Pacific Biological Pentylenediamine for Medicine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 43. Asia Pacific Biological Pentylenediamine for Medicine Consumption Market Share by Region (2020-2031)

Figure 44. China Biological Pentylenediamine for Medicine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 45. Japan Biological Pentylenediamine for Medicine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 46. South Korea Biological Pentylenediamine for Medicine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 47. China Taiwan Biological Pentylenediamine for Medicine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 48. Southeast Asia Biological Pentylenediamine for Medicine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 49. India Biological Pentylenediamine for Medicine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 50. Latin America, Middle East & Africa Biological Pentylenediamine for Medicine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 51. Latin America, Middle East & Africa Biological Pentylenediamine for Medicine Consumption Market Share by Country (2020-2031)

Figure 52. Mexico Biological Pentylenediamine for Medicine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 53. Brazil Biological Pentylenediamine for Medicine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 54. Turkey Biological Pentylenediamine for Medicine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 55. GCC Countries Biological Pentylenediamine for Medicine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 56. Global Production Market Share of Biological Pentylenediamine for Medicine by Type (2020-2031)

Figure 57. Global Production Value Market Share of Biological Pentylenediamine for Medicine by Type (2020-2031)

Figure 58. Global Biological Pentylenediamine for Medicine Price (US$/Ton) by Type (2020-2031)

Figure 59. Global Production Market Share of Biological Pentylenediamine for Medicine by Application (2020-2031)

Figure 60. Global Production Value Market Share of Biological Pentylenediamine for Medicine by Application (2020-2031)

Figure 61. Global Biological Pentylenediamine for Medicine Price (US$/Ton) by Application (2020-2031)

Figure 62. Biological Pentylenediamine for Medicine Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions